Literature DB >> 28268062

Regulating Damage from Sterile Inflammation: A Tale of Two Tolerances.

Shin-Rong Wu1, Pavan Reddy2.   

Abstract

The severity of immunopathology from non-infectious inflammation is mainly understood and is managed by targeting immune cells. However, the role of target tissues in determining damage severity has been largely overlooked. Here, we discuss the concept of 'tissue tolerance' for tissue-intrinsic programs that ameliorate organ damage in the setting of sterile immunopathology.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Year:  2017        PMID： 28268062      PMCID： PMC5384109          DOI： 10.1016/j.it.2017.02.005

Source DB:  PubMed          Journal:  Trends Immunol        ISSN： 1471-4906            Impact factor:   16.687


  12 in total

Review 1.  Tolerance of infections.

Authors:  Janelle S Ayres; David S Schneider
Journal:  Annu Rev Immunol       Date:  2012-01-03       Impact factor: 28.527

Review 2.  Accommodation in organ transplantation.

Authors:  Raymond J Lynch; Jeffrey L Platt
Journal:  Curr Opin Organ Transplant       Date:  2008-04       Impact factor: 2.640

Review 3.  Disease tolerance as a defense strategy.

Authors:  Ruslan Medzhitov; David S Schneider; Miguel P Soares
Journal:  Science       Date:  2012-02-24       Impact factor: 47.728

4.  Impact of glutathione S-transferase T1 gene polymorphisms on acute cellular rejection in living donor liver transplantation.

Authors:  Hideya Kamei; Satohiro Masuda; Taro Nakamura; Yasuhiro Fujimoto; Fumitaka Oike; Yasuhiro Ogura; Yasutsugu Takada; Nobuyuki Hamajima
Journal:  Transpl Immunol       Date:  2012-11-12       Impact factor: 1.708

5.  A20 protects mice from lethal liver ischemia/reperfusion injury by increasing peroxisome proliferator-activated receptor-alpha expression.

Authors:  Haley E Ramsey; Cleide G Da Silva; Christopher R Longo; Eva Csizmadia; Peter Studer; Virendra I Patel; Scott M Damrauer; Jeffrey J Siracuse; Soizic Daniel; Christiane Ferran
Journal:  Liver Transpl       Date:  2009-11       Impact factor: 5.799

6.  Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease.

Authors:  Alan M Hanash; Jarrod A Dudakov; Guoqiang Hua; Margaret H O'Connor; Lauren F Young; Natalie V Singer; Mallory L West; Robert R Jenq; Amanda M Holland; Lucy W Kappel; Arnab Ghosh; Jennifer J Tsai; Uttam K Rao; Nury L Yim; Odette M Smith; Enrico Velardi; Elena B Hawryluk; George F Murphy; Chen Liu; Lynette A Fouser; Richard Kolesnick; Bruce R Blazar; Marcel R M van den Brink
Journal:  Immunity       Date:  2012-08-24       Impact factor: 31.745

7.  Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation.

Authors:  V Ratanatharathorn; R A Nash; D Przepiorka; S M Devine; J L Klein; D Weisdorf; J W Fay; A Nademanee; J H Antin; N P Christiansen; R van der Jagt; R H Herzig; M R Litzow; S N Wolff; W L Longo; F B Petersen; C Karanes; B Avalos; R Storb; D N Buell; R M Maher; W E Fitzsimmons; J R Wingard
Journal:  Blood       Date:  1998-10-01       Impact factor: 22.113

8.  PRKDC mutations associated with immunodeficiency, granuloma, and autoimmune regulator-dependent autoimmunity.

Authors:  Anne-Laure Mathieu; Estelle Verronese; Gillian I Rice; Fanny Fouyssac; Yves Bertrand; Capucine Picard; Marie Chansel; Jolan E Walter; Luigi D Notarangelo; Manish J Butte; Kari Christine Nadeau; Krisztian Csomos; David J Chen; Karin Chen; Ana Delgado; Chantal Rigal; Christine Bardin; Catharina Schuetz; Despina Moshous; Héloïse Reumaux; François Plenat; Alice Phan; Marie-Thérèse Zabot; Brigitte Balme; Sébastien Viel; Jacques Bienvenu; Pierre Cochat; Mirjam van der Burg; Christophe Caux; E Helen Kemp; Isabelle Rouvet; Christophe Malcus; Jean-Francois Méritet; Annick Lim; Yanick J Crow; Nicole Fabien; Christine Ménétrier-Caux; Jean-Pierre De Villartay; Thierry Walzer; Alexandre Belot
Journal:  J Allergy Clin Immunol       Date:  2015-04-02       Impact factor: 10.793

9.  The Wnt agonist R-spondin1 regulates systemic graft-versus-host disease by protecting intestinal stem cells.

Authors:  Shuichiro Takashima; Masanori Kadowaki; Kazutoshi Aoyama; Motoko Koyama; Takeshi Oshima; Kazuma Tomizuka; Koichi Akashi; Takanori Teshima
Journal:  J Exp Med       Date:  2011-01-31       Impact factor: 14.307

10.  Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease.

Authors:  Nathan D Mathewson; Robert Jenq; Anna V Mathew; Mark Koenigsknecht; Alan Hanash; Vincent B Young; Subramaniam Pennathur; Marcel van den Brink; Tomomi Toubai; Katherine Oravecz-Wilson; Shin-Rong Wu; Yaping Sun; Corinne Rossi; Hideaki Fujiwara; Jaeman Byun; Yusuke Shono; Caroline Lindemans; Marco Calafiore; Thomas M Schmidt; Kenya Honda; Pavan Reddy
Journal:  Nat Immunol       Date:  2016-03-21       Impact factor: 25.606
View more
  4 in total

Review 1.  Immunopathology and biology-based treatment of steroid-refractory graft-versus-host disease.

Authors:  Tomomi Toubai; John Magenau
Journal:  Blood       Date:  2020-07-23       Impact factor: 22.113

2.  Murine Models of Steroid Refractory Graft-versus-Host Disease.

Authors:  Tomomi Toubai; Corinne Rossi; Isao Tawara; Chen Liu; Cynthia Zajac; Katherine Oravecz-Wilson; Daniel Peltier; Yaping Sun; Hideaki Fujiwara; Shin-Rong Wu; Mary Riwes; Israel Henig; Stephanie Kim; Pavan Reddy
Journal:  Sci Rep       Date:  2018-08-20       Impact factor: 4.379

Review 3.  How to Make an Immune System and a Foreign Host Quickly Cohabit in Peace? The Challenge of Acute Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation.

Authors:  Benoît Vandenhove; Lorenzo Canti; Hélène Schoemans; Yves Beguin; Frédéric Baron; Carlos Graux; Tessa Kerre; Sophie Servais
Journal:  Front Immunol       Date:  2020-10-21       Impact factor: 7.561

4.  Glucagon-Like Peptide-1 Is Associated With Systemic Inflammation in Pediatric Patients Treated With Hematopoietic Stem Cell Transplantation.

Authors:  Maria Ebbesen; Hannelouise Kissow; Bolette Hartmann; Katrine Kielsen; Kaspar Sørensen; Sara Elizabeth Stinson; Christine Frithioff-Bøjsøe; Cilius Esmann Fonvig; Jens-Christian Holm; Torben Hansen; Jens Juul Holst; Klaus Gottlob Müller
Journal:  Front Immunol       Date:  2021-12-08       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.